Gilead Sciences (GILD)

Sector:Health Care
Super Investor Stats:
Ownership count:3
Ownership rank:221
% of all portfolios:0.06%
Hold Price * :$73.97
History Portfolio Manager Activity ▼ Share change % change to portfolio
Q4  2013
≡ David Rolfe - Wedgewood Partners Reduce 28.36% 712,930 1.11
Q3  2013
≡ David Rolfe - Wedgewood Partners Add 2.21% 54,402 0.08
≡ Daniel Loeb - Third Point Buy 500,000 0.77
Q2  2013
≡ David Rolfe - Wedgewood Partners Add 9.22% 207,579 0.31
Q1  2013
≡ David Rolfe - Wedgewood Partners Reduce 3.03% 70,285 0.12
Q4  2012
≡ David Rolfe - Wedgewood Partners Add 29.15% 524,100 0.89
Q3  2012
≡ David Rolfe - Wedgewood Partners Reduce 29.49% 751,906 1.59
Q2  2012
≡ David Rolfe - Wedgewood Partners Add 6.56% 156,970 0.31
Q1  2012
≡ David Rolfe - Wedgewood Partners Reduce 1.44% 34,856 0.07
Q4  2011
≡ Dodge & Cox Sell 100.00% 5,438,096 0.31
Q1  2011
≡ Dodge & Cox Reduce 0.52% 28,600 0.00
Q4  2010
≡ Dodge & Cox Add 57.06% 1,986,112 0.08
Q3  2010
≡ Dodge & Cox Buy 3,480,584 0.16

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.